Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376643239> ?p ?o ?g. }
- W4376643239 endingPage "405" @default.
- W4376643239 startingPage "397" @default.
- W4376643239 abstract "Mammalian target of rapamycin (mTOR) controls cellular anabolism, and mTOR signaling is hyperactive in most cancer cells. As a result, inhibition of mTOR signaling benefits cancer patients. Rapamycin is a US Food and Drug Administration (FDA)-approved drug, a specific mTOR complex 1 (mTORC1) inhibitor, for the treatment of several different types of cancer. However, rapamycin is reported to inhibit cancer growth rather than induce apoptosis. Pyruvate dehydrogenase complex (PDHc) is the gatekeeper for mitochondrial pyruvate oxidation. PDHc inactivation has been observed in a number of cancer cells, and this alteration protects cancer cells from senescence and nicotinamide adenine dinucleotide (NAD+) exhaustion. In this paper, we describe our finding that rapamycin treatment promotes pyruvate dehydrogenase E1 subunit alpha 1 (PDHA1) phosphorylation and leads to PDHc inactivation dependent on mTOR signaling inhibition in cells. This inactivation reduces the sensitivity of cancer cells' response to rapamycin. As a result, rebooting PDHc activity with dichloroacetic acid (DCA), a pyruvate dehydrogenase kinase (PDK) inhibitor, promotes cancer cells' susceptibility to rapamycin treatment in vitro and in vivo.哺乳动物雷帕霉素靶蛋白(mTOR)控制细胞的合成代谢,并且在大多数的肿瘤细胞中mTOR信号通路高度活化,因此抑制mTOR信号通路对癌症患者有益。雷帕霉素是一种美国食品药品监督管理局(FDA)批准的临床一线药物,是mTORC1的特异性抑制剂,用于治疗多种不同类型的癌症。然而,研究发现雷帕霉素仅抑制肿瘤细胞的增殖并不引起细胞的凋亡。丙酮酸脱氢酶复合体(PDHc)在线粒体丙酮酸氧化过程起着决定作用。许多肿瘤细胞中的PDHc处于失活状态,这一变化可以使肿瘤细胞免于衰老和NAD+耗竭。在本研究中,发现雷帕霉素处理细胞导致依赖mTOR信号通路抑制的丙酸脱氢酶α1(PDHA1)磷酸化水平升高,并导致PDHc酶活降低。PDHc失活直接引起肿瘤细胞对雷帕霉素敏感度下降。因此,在体内和体外的实验中通过使用丙酮酸脱氢酶激酶(PDK)的抑制剂二氯乙酸(DCA)可以重新激活PDHc的活力,进而增加肿瘤细胞对雷帕霉素的敏感性。." @default.
- W4376643239 created "2023-05-17" @default.
- W4376643239 creator A5029665855 @default.
- W4376643239 creator A5035169366 @default.
- W4376643239 creator A5056177303 @default.
- W4376643239 creator A5078632164 @default.
- W4376643239 date "2023-05-01" @default.
- W4376643239 modified "2023-10-13" @default.
- W4376643239 title "二氯乙酸联合雷帕霉素协同抑制肿瘤进程" @default.
- W4376643239 cites W1949632792 @default.
- W4376643239 cites W1965626427 @default.
- W4376643239 cites W1980396381 @default.
- W4376643239 cites W1983698019 @default.
- W4376643239 cites W1983824186 @default.
- W4376643239 cites W2026034536 @default.
- W4376643239 cites W2026252608 @default.
- W4376643239 cites W2026351725 @default.
- W4376643239 cites W2029348880 @default.
- W4376643239 cites W2053291546 @default.
- W4376643239 cites W2053874502 @default.
- W4376643239 cites W2057650061 @default.
- W4376643239 cites W2075594379 @default.
- W4376643239 cites W2088417711 @default.
- W4376643239 cites W2090817847 @default.
- W4376643239 cites W2097104496 @default.
- W4376643239 cites W2114859236 @default.
- W4376643239 cites W2147071344 @default.
- W4376643239 cites W2152289580 @default.
- W4376643239 cites W2157360228 @default.
- W4376643239 cites W2164524616 @default.
- W4376643239 cites W2286842342 @default.
- W4376643239 cites W2407198816 @default.
- W4376643239 cites W2518718875 @default.
- W4376643239 cites W2550229249 @default.
- W4376643239 cites W2597290376 @default.
- W4376643239 cites W2740618823 @default.
- W4376643239 cites W2765597781 @default.
- W4376643239 cites W2773300145 @default.
- W4376643239 cites W2794913319 @default.
- W4376643239 cites W2898144712 @default.
- W4376643239 cites W2898151139 @default.
- W4376643239 cites W2902059521 @default.
- W4376643239 cites W2947131379 @default.
- W4376643239 cites W2987558403 @default.
- W4376643239 cites W3113834486 @default.
- W4376643239 cites W3139125229 @default.
- W4376643239 cites W3192535679 @default.
- W4376643239 cites W4226471905 @default.
- W4376643239 doi "https://doi.org/10.1631/jzus.b2200356" @default.
- W4376643239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37190889" @default.
- W4376643239 hasPublicationYear "2023" @default.
- W4376643239 type Work @default.
- W4376643239 citedByCount "0" @default.
- W4376643239 crossrefType "journal-article" @default.
- W4376643239 hasAuthorship W4376643239A5029665855 @default.
- W4376643239 hasAuthorship W4376643239A5035169366 @default.
- W4376643239 hasAuthorship W4376643239A5056177303 @default.
- W4376643239 hasAuthorship W4376643239A5078632164 @default.
- W4376643239 hasBestOaLocation W43766432392 @default.
- W4376643239 hasConcept C121608353 @default.
- W4376643239 hasConcept C181199279 @default.
- W4376643239 hasConcept C184235292 @default.
- W4376643239 hasConcept C185592680 @default.
- W4376643239 hasConcept C2776901170 @default.
- W4376643239 hasConcept C2777949483 @default.
- W4376643239 hasConcept C43060935 @default.
- W4376643239 hasConcept C502942594 @default.
- W4376643239 hasConcept C54355233 @default.
- W4376643239 hasConcept C55493867 @default.
- W4376643239 hasConcept C62478195 @default.
- W4376643239 hasConcept C75520062 @default.
- W4376643239 hasConcept C86554907 @default.
- W4376643239 hasConcept C86803240 @default.
- W4376643239 hasConcept C88099638 @default.
- W4376643239 hasConcept C9506865 @default.
- W4376643239 hasConcept C96232424 @default.
- W4376643239 hasConcept C98274493 @default.
- W4376643239 hasConcept C98490376 @default.
- W4376643239 hasConceptScore W4376643239C121608353 @default.
- W4376643239 hasConceptScore W4376643239C181199279 @default.
- W4376643239 hasConceptScore W4376643239C184235292 @default.
- W4376643239 hasConceptScore W4376643239C185592680 @default.
- W4376643239 hasConceptScore W4376643239C2776901170 @default.
- W4376643239 hasConceptScore W4376643239C2777949483 @default.
- W4376643239 hasConceptScore W4376643239C43060935 @default.
- W4376643239 hasConceptScore W4376643239C502942594 @default.
- W4376643239 hasConceptScore W4376643239C54355233 @default.
- W4376643239 hasConceptScore W4376643239C55493867 @default.
- W4376643239 hasConceptScore W4376643239C62478195 @default.
- W4376643239 hasConceptScore W4376643239C75520062 @default.
- W4376643239 hasConceptScore W4376643239C86554907 @default.
- W4376643239 hasConceptScore W4376643239C86803240 @default.
- W4376643239 hasConceptScore W4376643239C88099638 @default.
- W4376643239 hasConceptScore W4376643239C9506865 @default.
- W4376643239 hasConceptScore W4376643239C96232424 @default.
- W4376643239 hasConceptScore W4376643239C98274493 @default.
- W4376643239 hasConceptScore W4376643239C98490376 @default.
- W4376643239 hasIssue "5" @default.